Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Sun, 22 Jul 18 04:58:54 +0000 Sun, 22 Jul 18 04:58:54 +0000 FDA Approves First Therapy for Relapsed, Refractory AML with IDH1 Mutation http://www.pharmacytimes.com/news/fda-approves-first-therapy-for-relapsed-refractory-aml-with-idh1-mutation- http://www.pharmacytimes.com/news/fda-approves-first-therapy-for-relapsed-refractory-aml-with-idh1-mutation- Fri, 20 Jul 18 18:37:00 +0000 FDA Approves First Smallpox Treatment to Counter Bioterrorism http://www.pharmacytimes.com/product-news/fda-approves-first-smallpox-treatment-to-counter-bioterrorism http://www.pharmacytimes.com/product-news/fda-approves-first-smallpox-treatment-to-counter-bioterrorism Officials with the FDA have approved tecovirimat (TPOXX, SIGA), the first drug with an indication for the treatment of smallpox, to boost preparedness in the event of a bioterror attack Mon, 16 Jul 18 15:00:00 +0000 FDA Approves Enzalutamide for Non-Metastatic Castration-Resistant Prostate Cancer http://www.pharmacytimes.com/news/fda-approves-enzalutamide-for-nonmetastatic-castrationresistant-prostate-cancer http://www.pharmacytimes.com/news/fda-approves-enzalutamide-for-nonmetastatic-castrationresistant-prostate-cancer With this new indication, enzalutamide is the first and only FDA-approved oral medication for both non-metastatic and metastatic CRPC. Mon, 16 Jul 18 08:58:00 +0000 Students to Switch Places for Unique Pharmacy Experiences http://www.pharmacytimes.com/news/students-to-switch-places-for-unique-pharmacy-experiences http://www.pharmacytimes.com/news/students-to-switch-places-for-unique-pharmacy-experiences Student pharmacists at 2 universities in vastly different communities will learn how the other half practices pharmacy during a new program that will send each group across the country. Mon, 16 Jul 18 06:37:00 +0000 Voluntary Recall of Several Medicines Containing Valsartan Following Impurity Detection http://www.pharmacytimes.com/news/voluntary-recall-of-several-medicines-containing-valsartan-following-impurity-detection- http://www.pharmacytimes.com/news/voluntary-recall-of-several-medicines-containing-valsartan-following-impurity-detection- Some companies are recalling all lots of non-expired products that contain the ingredient valsartan supplied by a third-party. Sun, 15 Jul 18 20:48:00 +0000 Cycling Pharmacists Using Pedal Power in Upcoming Ride http://www.pharmacytimes.com/news/cycling-pharmacists-using-pedal-power-in-upcoming-ride- http://www.pharmacytimes.com/news/cycling-pharmacists-using-pedal-power-in-upcoming-ride- Pharmacists will&nbsp;provide first aid and over-the-counter treatments along the RAGBRAI route, which stretches more than 400 miles across Iowa. Sun, 15 Jul 18 20:32:00 +0000 PTCB Sees Success in Advanced Technician Certification Program http://www.pharmacytimes.com/news/ptcb-sees-success-in-advanced-technician-certification-program http://www.pharmacytimes.com/news/ptcb-sees-success-in-advanced-technician-certification-program In a sign of the profession&rsquo;s evolution, more than 300 pharmacy technicians have now been certified as Compounded Sterile Preparation Technicians, according to the Pharmacy Technician Certification Board. Fri, 13 Jul 18 15:00:00 +0000 ASHP, ACPE Release Revised National Standards for Pharmacy Technician Accreditation http://www.pharmacytimes.com/news/ashp-acpe-release-revised-national-standards-for-pharmacy-technician-accreditation- http://www.pharmacytimes.com/news/ashp-acpe-release-revised-national-standards-for-pharmacy-technician-accreditation- Newly revised standards support quality education, and training for the technician workforce, according to the organizations. Wed, 11 Jul 18 15:10:00 +0000 Nivolumab, Ipilimumab Combo Approved by FDA for MSI-H/dMMR Colorectal Cancer http://www.pharmacytimes.com/news/nivolumab-ipilimumab-combo-approved-by-fda-for-msihdmmr-colorectal-cancer http://www.pharmacytimes.com/news/nivolumab-ipilimumab-combo-approved-by-fda-for-msihdmmr-colorectal-cancer The FDA has granted an accelerated approval to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of eligible patients aged 12 years and older&nbsp;with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer (mCRC). Wed, 11 Jul 18 13:37:00 +0000 Study: Upfront Atezolizumab/Nab-Paclitaxel Treatment for TNCB Reduces Risk of Disease Progression http://www.pharmacytimes.com/news/study-upfront-atezolizumabnabpaclitaxel-treatment-for-tncb-reduces-risk-of-disease-progression http://www.pharmacytimes.com/news/study-upfront-atezolizumabnabpaclitaxel-treatment-for-tncb-reduces-risk-of-disease-progression Tue, 03 Jul 18 13:00:00 +0000 Pharmacists Need to Remain Aware of Drug Shortages and Be Prepared to Take Action http://www.pharmacytimes.com/news/pharmacists-need-to-be-aware-of-drug-shortage-risks-and-take-action-- http://www.pharmacytimes.com/news/pharmacists-need-to-be-aware-of-drug-shortage-risks-and-take-action-- Being prepared is vital to understanding and resolving future drug shortages.&nbsp;<br /> &nbsp; Mon, 02 Jul 18 15:46:00 +0000 Amazon Enters the Pharmacy World with Acquisition of PillPack http://www.pharmacytimes.com/news/amazon-enters-the-pharmacy-world-with-acquisition-of-pillpack-- http://www.pharmacytimes.com/news/amazon-enters-the-pharmacy-world-with-acquisition-of-pillpack-- Amazon will start prescription delivery with a focus on customer service and convenience.&nbsp; Thu, 28 Jun 18 17:19:00 +0000 FDA Advisory Committee Recommends Against Approving Abuse-Deterrent Pain Med http://www.pharmacytimes.com/news/fda-advisory-committee-recommends-against-approving-abusedeterrent-pain-med http://www.pharmacytimes.com/news/fda-advisory-committee-recommends-against-approving-abusedeterrent-pain-med The FDA voted against recommendign oxycodone extended-release capsules (REMOXY ER, Pain Therapeutics) for approval for the management of pain severe enough to require long-term, around-the-clock opioid treatment, during a joint meeting of the agency&rsquo;s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), and the Drug Safety and Risk Management Advisory Committee (DSARM). Wed, 27 Jun 18 21:17:00 +0000 Combo Treatment for Advanced BRAF-Mutant Melanoma Receives FDA Approval http://www.pharmacytimes.com/news/combo-treatment-for-advanced-brafmutant-melanoma-receives-fda-approval http://www.pharmacytimes.com/news/combo-treatment-for-advanced-brafmutant-melanoma-receives-fda-approval The FDA has granted approval to Array BioPharma&rsquo;s encorafenib (Braftovi) capsules in combination with binimetinib (Mektovi) tablets for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E&nbsp;or BRAFV600K&nbsp;mutation. Wed, 27 Jun 18 19:28:00 +0000 FDA Approves Groundbreaking Drug for Treating Rare, Severe Forms of Epilepsy http://www.pharmacytimes.com/news/fda-approves-groundbreaking-drug-for-treating-rare-severe-forms-of-epilepsy http://www.pharmacytimes.com/news/fda-approves-groundbreaking-drug-for-treating-rare-severe-forms-of-epilepsy Officials with the FDA have approved cannabidiol oral solution (Epidiolex) for the treatment of seizures associated with 2 rare and severe forms of epilepsy, Lennox-Gastaut syndrome, and Dravet syndrome, in patients aged 2 years and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana, and is the first FDA approval of a drug for the treatment of patients with Dravet syndrome. Mon, 25 Jun 18 18:15:00 +0000 Multimed Packaging Shown to Improve Medication Adherence http://www.pharmacytimes.com/news/multimed-packaging-shown-to-improve-medication-adherence http://www.pharmacytimes.com/news/multimed-packaging-shown-to-improve-medication-adherence An improvement in clinical outcomes and medication adherence rates when patients used medication therapy management services and multimed blister card packaging was clearly shown in a recent study. Thu, 21 Jun 18 19:32:00 +0000 What Challenges Do Independent Pharmacists Face Today? http://www.pharmacytimes.com/news/what-challenges-do-independent-pharmacists-face-today http://www.pharmacytimes.com/news/what-challenges-do-independent-pharmacists-face-today Mon, 18 Jun 18 19:58:00 +0000 FDA Approves First Generic of Drug Used to Treat Opioid Dependence http://www.pharmacytimes.com/news/fda-approves-first-generic-of-drug-used-to-treat-opioid-dependence http://www.pharmacytimes.com/news/fda-approves-first-generic-of-drug-used-to-treat-opioid-dependence Agency officials have given the green light to versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy&#39;s Laboratories SA) sublingual film. Thu, 14 Jun 18 21:22:00 +0000 Bevacizumab with Chemotherapy Approved by FDA for Ovarian Cancer http://www.pharmacytimes.com/news/bevacizumab-with-chemotherapy-approved-by-fda-for-ovarian-cancer http://www.pharmacytimes.com/news/bevacizumab-with-chemotherapy-approved-by-fda-for-ovarian-cancer Officials with the FDA have approved bevacizumab (Avastin, Genentech) for patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer in combination with carboplatin and paclitaxel. Wed, 13 Jun 18 19:32:00 +0000 Pharmacist-Physician Collaborations Shown to be Mutually Beneficial http://www.pharmacytimes.com/news/pharmacistphysician-collaborations-shown-to-be-mutually-beneficial http://www.pharmacytimes.com/news/pharmacistphysician-collaborations-shown-to-be-mutually-beneficial At the American Pharmacy Purchasing Alliance&rsquo;s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work. &nbsp; Mon, 11 Jun 18 11:34:00 +0000 Panel: Independent Pharmacies Need Changes to PBM Relationship http://www.pharmacytimes.com/news/panel-independent-pharmacies-need-changes-to-pbm-relationship http://www.pharmacytimes.com/news/panel-independent-pharmacies-need-changes-to-pbm-relationship Change is needed to create a better working relationship between pharmacy benefit managers (PBMs) and independent pharmacies, according to a panel of experts at the American Pharmacy Purchasing Alliance (APPA) conference in Orlando, FL. Sat, 09 Jun 18 11:55:00 +0000 5 Ways Pharmacists Can Help Prevent Suicide http://www.pharmacytimes.com/news/5-ways-pharmacists-can-help-prevent-suicide http://www.pharmacytimes.com/news/5-ways-pharmacists-can-help-prevent-suicide The deaths this week of Kate Spade and&nbsp;Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented. Fri, 08 Jun 18 18:00:00 +0000 Parata Systems and Pharmacy Times Announce Judges for 2018 Next-Generation Pharmacist Awards http://www.pharmacytimes.com/news/parata-systems-and-pharmacy-times-announce-judges-for-2018-nextgeneration-pharmacist-awards http://www.pharmacytimes.com/news/parata-systems-and-pharmacy-times-announce-judges-for-2018-nextgeneration-pharmacist-awards An esteemed panel will deliberate more than 600 nominations. Fri, 08 Jun 18 14:00:00 +0000 First Biosimilar to Pegfilgrastim Approved by FDA http://www.pharmacytimes.com/news/first-biosimilar-to-pegfilgrastim-approved-by-fda http://www.pharmacytimes.com/news/first-biosimilar-to-pegfilgrastim-approved-by-fda The FDA has approved pegfilgrastim-jmdb (Fulphila, Mylan GmbH) as the first biosimilar to pegfilgrastim (Neulasta) to help reduce the chance of fever-causing infection for a population of patients with cancer. Mon, 04 Jun 18 21:44:00 +0000 Combination Shows Promise for Treating Advanced Non Small Cell Lung Cancer http://www.pharmacytimes.com/news/combination-shows-promise-for-treating-advanced-non-small-cell-lung-cancer http://www.pharmacytimes.com/news/combination-shows-promise-for-treating-advanced-non-small-cell-lung-cancer Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non&ndash;small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.&nbsp; Mon, 04 Jun 18 15:53:00 +0000